Ottawa Hospital Research Institute

$637,634.00 CAD

≈ 8 Canadians' average pay for a year
Department
National Research Council Canada
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Recipient country
Canada
Fiscal year
2022-2023
Agreement period
July 20, 2022 – February 20, 2025
Reference
nrc-cnrc:172-2021-2022-Q2-992466

Published purpose

This project will support process and assay development efforts currently ongoing at the NRC for an adeno-associated virus (AAV)-based next generation LPLD gene therapy. The goal of this project will be to accelerate the rate at which this therapy is GMP manufactured and subsequently ready to be tested in the clinic, by formally combining the efforts, experience and expertise of both the NRC and BMC-VMF to finalize process parameters and develop and qualify key GMP release tests that will be executed at the BMC.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported August 3, 2026 from open.canada.ca Grants & Contributions